Company Filing History:
Years Active: 2004-2019
Title: The Innovative Journey of Patricia Ann Basford
Introduction
Patricia Ann Basford, an esteemed inventor based in Sandwich, GB, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio consisting of eight patents, her work exemplifies dedication and innovation, particularly in the creation of polymorphic forms of vital pharmaceutical compounds.
Latest Patents
Among her latest innovations, Basford has developed novel polymorphic forms of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one. These polymorphic forms have potential applications as components of pharmaceutical compositions for treating mammalian diseases mediated by poly(ADP-ribose) polymerase activity, including cancer. This invention represents a significant advancement in therapeutic options and highlights her expertise in medicinal chemistry.
Career Highlights
Throughout her career, Basford has collaborated with leading pharmaceutical companies, most notably Pfizer Corporation and Agouron Pharmaceuticals, Inc. Her extensive experience in research and development has been instrumental in driving innovation within these organizations and advancing the field of medication development.
Collaborations
Patricia Ann Basford has worked alongside remarkable colleagues, including Anthony Michael Campeta and Adam Gillmore. These collaborations have not only enhanced her research endeavors but have also contributed to the wider scientific community's understanding of pharmaceutical compounds.
Conclusion
Patricia Ann Basford's contributions to the field of pharmaceuticals through her patents and collaborations are commendable. Her innovative spirit and dedication to improving healthcare outcomes through her inventions make her a significant figure in the world of inventors. As she continues to push the boundaries of research, the impact of her work will surely resonate in the fight against critical diseases.